In English | En español
Questions About Cancer? 1-800-4-CANCER

Cancer Drug Information

  • Posted: 01/25/2007
  • Updated: 07/31/2014

Page Options

  • Print This Page
  • Email This Document

Gemtuzumab Ozogamicin

listen  (gem-TOO-zoo-mab OH-zoh-ga-MIH-sin )

This page contains brief information about gemtuzumab ozogamicin and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s): Mylotarg
FDA Approved: No

Use in Cancer

As of June 21, 2010, gemtuzumab ozogamicin is no longer available to new patients, due to concerns about whether the drug is safe and effective. Patients who are already being treated with this drug may continue their treatment, depending on their doctor's advice. To learn more, see Gemtuzumab Ozogamicin Voluntarily Withdrawn from U.S. Markets.

Gemtuzumab Ozogamicin was originally approved to treat:

Gemtuzumab ozogamicin continues to be studied in the treatment of leukemia and other conditions.

More About Gemtuzumab Ozogamicin

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Gemtuzumab Ozogamicin - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Targeted Cancer Therapies - Information about the use of this drug to treat cancer.

Clinical Trials Accepting Patients

Find Clinical Trials for Gemtuzumab Ozogamicin - Check for trials from NCI's list of cancer clinical trials now accepting patients.

Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.


Back to TopBack to Top